Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on the Pharmacokinetics of DA-5223 in Healthy Adult Subjects
NCT07007520Phase 1Withdrawn
- Sponsor
- Dong-A ST
- Start
- Nov 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of DA-5223 (2 arms), sponsored by Dong-A ST. Primary endpoints: Area Under the Concentration-Time Curve From Time Zero to the Last Quantifiable Concentration at 12 hours and Maximum Observed Plasma Concentration at 12 hours. Planned start Nov 2025; status: withdrawn.
02
Drugs
DA-5223
Beyond the preview
Go deeper on NCT07007520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07007520.